Snajdauf J, Zeman L, Horn M, Koutecký J, Smelhaus V, Horák J, Kodet R
Klinika dĕtské chirurgie FN Motol, 2. lékarské fakulty UK, Praze.
Rozhl Chir. 1994 Feb;73(1):31-3.
The authors submit their experience with the surgical treatment of retroperitoneal neuroblastoma, which is one of the most frequent solid tumours of child age. They describe the principles of the surgical technique with emphasis on radical removal of the tumour even in the area of large blood vessels. They emphasize the advantage of using an ultrasonic surgical aspirator (CUSA, Valleylab Co., Pfizer) which makes it possible to remove residues of the tumour without damaging the large blood vessels. During the period between 1987-1992 they treated at the Motol Faculty Hospital 69 children with retroperitoneal neuroblastoma. Of these 60 were operated. In the first stage of the disease 9 patients were operated, all survive. In the second stage 4 patients were operated, 75% survive, in the third stage 24 patients 50% survive, in the fourth stage 20 of 29 patients were operated and 11 (38%) survive. In stage IV--S three patients were operated, one survives. The total survival of patients during the investigation period is 52%.
作者介绍了他们对腹膜后神经母细胞瘤进行手术治疗的经验，腹膜后神经母细胞瘤是儿童期最常见的实体瘤之一。他们描述了手术技术的原则，重点是即使在大血管区域也要彻底切除肿瘤。他们强调使用超声手术吸引器（CUSA，瓦里安公司，辉瑞制药）的优势，这使得在不损伤大血管的情况下清除肿瘤残余成为可能。1987年至1992年期间，他们在莫托尔医学院附属医院治疗了69例腹膜后神经母细胞瘤患儿。其中60例接受了手术。在疾病的第一阶段，9例患者接受了手术，全部存活。在第二阶段，4例患者接受了手术，75%存活；在第三阶段，24例患者中50%存活；在第四阶段，29例患者中的20例接受了手术，11例（38%）存活。在IV-S期，3例患者接受了手术，1例存活。研究期间患者的总生存率为52%。
